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SUMMARY
Twenty-nine adult patients with intracranial ependymoma received postoperative radiotherapy with curative intent
between 1978 and 1993. The primary site was located above tentorium in 17 cases and below in 12. In 17
patients the tumours were classified as low-grade. Most patients with high-grade lesions received radiotherapy to
the craniospinal axis, low-grade tumours received a more limited treatment. Actuarial survival rates at 5 and 10
years were 59% and 51% in the whole group respectively. Histologically actuarial survival rates at 5 and 10 years
were 50% and 41 % for high-grade tumours, and 65% and 57% for low-grade lesions respectively. This difference
was not statistically significant at 0,05 level.
The primary site was the most common pattern of failure.
INTRODUCTION
Ependymomas are infrequent tumours that
account for 2-5% of all neoplasms of the central
nervous system, and at least half of them occur
in the first two decades of life. They typically
project from an ependymal surface, most
commonly in the floor of the fourth ventricle or
lateral and third ventricles, but can also arise in
the cerebellopontine angle, the region of the
spinal cord, or from the filum terminale [1].
About two thirds are infratentorial, and about
one third supratentorial. Tumours of the
posterior fossa predominate in young children
and adolescents [2].
Surgery has always been the primary
treatment for ependymomas, whose, complete
removal due to their location is often impossible
without significant morbidity. Consequently,
results in a pure surgical series are generally
disappointing with survival rates less than 30%
after 5 years [3]. Therefore the postoperative
radiation therapy plays an important role, and
has consistently improved survival [4].
This paper describes a retrospective study of 29
adult patients treated with postoperative
irradiation, and discusses therapeutic
implications of the findings.
MATERIALS AND METHODS
Patients
Between 1978 and 1993, 29 adult patients
with histologically verified primary intracranial
ependymoma were referred to the Maria
Skfodowska - Curie Memorial Institute Center
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in Krak6w for further treatment after initial
surgery. The 18 female and 11 male patients
ranged from 17 to 57 years (mean age 38
years). The tumour was supratentorial in 17
(59%) patients and infratentorial in 12 (41%).
The most commonly involved side was the
'fourth ventricle, among supratentorial tumours,
cerebral hemispheres beJng most frequently
involved often with association with the third
and/or lateral ventricles.
All patients underwent open craniotomy: only
for biopsy in 1 (3%) case, for subtotal resection
in 24 (83%) cases, and for gross total removal
in four (14%) cases. The same pathologist
evaluated all surgical specimens according to
the criteria of the WHO [5]. By histological
subtype, 12 (41 %) tumours were of the cellular
type, 12 were anaplastic, and 5 (10%)
represented mixed a cellular and papillary
variant. All tumours were graded on an
ascending scale of malignancy from 1 to 4.
Grading was based upon the recognition of
three features: mitotic figures, endothelial
proliferation and necrosis, using the following
scale: grade 1 - devoid of mitotic activity,
grade 2 - mitotic figures present with no
endothelial proliferation or necrosis, grade 3-
mitotic figures plus either endothelial
proliferation or necrosis or both, and grade 4-
basic features similar to those of primitive
neuroectodermal tumour but with evidence of
ependymal differentiation. Overall, 17 (59%)
tumours were low-grade and 12 (41%) were
those of high-grade. The distribution of patho-
clinical characteristics of 29 patients is given in
Table 1.
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Table 1. Patients characteristics.
Characteristics
Age (years)
40 and less
More than 40
Gender
Male
Female
Tumour location
Supratentorial
Infratentorial
Surgery
Biopsy
Partial resection
Total resection
Histology
Low-grade (1 and 2)
High-grade (3 and 4)
RADIATION THERAPY
All patients were treated with either a 10 MeV
linear accelerator, or with GOCo. The radiotherapy
treatment fields are listed in Table 2.
The brain was treated with two opposed
lateral fields (for infratentorial tumours the
upper cervical region of the spine was included
in the radiation field). All spine fields were
irradiated with two direct posterior beams with
appropriate shifting gaps. Partial brain fields
were planned by estimating the tumour volume
from radiographic studies. The target volume
encompassed a CT scan contrast-enhanced
Table 2. Radiation treatment fields by tumour location and grade.
Number of patients
15
14
11
18
17
12
1
24
4
17
12
zone plus a margin of 2 cm. In the pre-CT era
the tumour volume was based on the
neurosurgeon's description of the anatomic
area of tumour involvement. Brain doses,
calculated at midplane, ranged from 40 to 50
Gy (median 46 Gy), whereas spinal cord
doses, calculated at the appropriate cord
depth, ranged from 30 to 35 Gy (median 32
Gy). The median doses per fraction for the
brain and spinal cord were 180 and 135 cGy,
respectively. In a partial brain irradiation the
dose to the primary site was 56 to 60 Gy
(median, 58 Gy), delivered in 24-30 fractions.
Treatment fields Supratentorial
Low-grade High-grade
Infratentorial
Low-grade High-grade
Partial brain
Whole brain
Craniospinal axis
10
2
2
2
1
2
1
2
1
1
5
SUPPORTIVE TREATMENT STATISTICAL CONSIDERATION
Systemic anticonvulsants were administered
to all patients during irradiation, steroids were
given only as symptomatic medication required
to control cerebral oedema.
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A minimum follow-up was five years. The
length of survival was measured from the day
of surgery, survival plots were generated using
the Kaplan-Meier product limit method [6], and
comparisons were made using the Gehan
modification of the Wilcoxon test [7].
Rep. Pract. Oneol. Radiother. 5 (3) 2000
Glinski et al.: Intracranial ependymona in adult patients ...
RESULTS
TOLERANCE
The treatment was generally well tolerated,
only one patient who received craniospinal axis
irradiation, had onset of intermittent vomiting
which caused a two day break in irradiation.
SURVIVAL
At the time of this analysis, 14 of the 29
patients were known to have died. The overall
actuarial survival of 29 patients is presented in
Fig. 1. Actuarial survival rates at 5 and 10
years were 59% and 51 %, respectively. The
probability of survival according to the
histological grade is given in Fig. 2.
Actuarial survival rates at 5 and 10 years
were 50% and 41 % for high-grade, 65% and
57% for low-'grade tumours respectively. This
difference is not statistically significant
(p=O,3283).
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Fig. 1. The actuarial overall survival of 29 adult patients with· intracranial ependymomas treated
with postoperative irradiation.
Survival Function
o Complete + Censored
Fig. 2. The actuarial survival of 29 adult patients with intracranial ependymomas treated with
postoperative irradiation according to the histological grade.
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PATTERNS OF FAILURE
Twelve patients were considered appropriate
for the analysis of patterns of failure (for two
patients reliable information about the site of
recurrence was lacking). Eleven tumours
Table 3. Patterns of failure (12 eligible patients).
recurred at the primary site, one patient had
metastasis to the spine (a high-grade
infratentorial tumour treated with whole brain
radiotherapy). Patterns of failure of 12 eligible
patients are summarised in Table 3.
No Grade Tumour site Radiation field Dose (Gy) Location of
failure
1. 1 IF Partial brain 50 Brain
2. 1 IF Partial brain 55 Brain
3. 2 ST Whole brain 50 Brain
4. 2 ST Partial brain 56 Brain
5. 2 ST Partial brain 60 Brain
6. 2 ST Partial·brain 60 Brain
7. 3 ST Partial brain 56 Brain
8. 3 ST Whole brain 45 Brain
9. 3 IF Whole brain 45 Spine
10. 4 IF Craniospinal axis 35/50x Brain
11. 4 IF Craniospinal axis 34/50x Brain
12. 4 IF Craniospinal axis 30/50x Brain
IF- infratentorial, ST- Supratentorial, x - dose at the craniospinal axis/dose at the involved site
DISCUSSION
Intracranial ependymomas of adult patients
are relatively infrequent [8,9]. We report the
long-term results of a cohort of 29 adult
patients with these tumours. The survival rates
at 5 and 10 years are shown in Table 4, in
which results of other published series are also
reported. The results referred to by Show et al.
and more recently by Zorlu et aI., seem to be
very interesting reporting 10-year survival rates
of 60% and 57% respectively [9,10]. In the
series of 10 adult patients from the New York
Medical Center, with a median follow-up of 64
months, seven patients were alive and free oJ
disease, while two died of intercurrent disease
without evidence of tumour at 7 and 9 years
following treatment. The authors conclude that
postoperative radiotherapy is effective in
preventing regrowth of intracranial
ependymoma following subtotal resection in
adults. Treatment fields should cover the initial
tumour bed with a 1-2 cm margin to avoid late
radiation damage [8].
Table 4. Results of postoperative irradiation of intracranial ependymomas in adult patients.
Author Number of patients 5-year survival 1a-year survival
(West et aL, 1985) 13 48% 42%
(Wallner et al., 1986) 12 58% 42%
(Shaw et aI., 1987) 15 73% 60%
(Oi Marco et aL, 1988) 33 48% 38%
(Vanuytsel et aI., 1991) 35 57% 48%
(Zorlu et aI., 1994) 21 62% 57%
(McLaughlin et aI., 1998) 18 51% 46%
Present series 29 59% 41%
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It should be noted that in most series
reported the principles of radiation treatments
varied videly. It is mainly the whole brain
irradiation, or partial brain irradiation that was
employed, whereas craniospinal axis was used
only in fewer cases. Today, the benefit of
postoperative irradiation in intracranial
ependymomas is well accepted, the main
controversy centering on the field size in
radiation therapy. For supratentorial low-grade
tumours there is general agreement as to the
local irradiation or whole brain treatment
[11,12]. For infratentorial low-grade lesions a
number of treatment policies have been
proposed from local fields to craniospinal
irradiation [13, 14].
For high-grade tumours craniospinal axis
irradiation is considered by most authors as
the treatment of choice [15]. The need for
whole brain or spinal irradiation is strictly
related to the probability of seeding of
neoplastic cells, which is difficult to asses, and
in this case frequencies range from nil to more
than 60% [4, 13]. A review of the clinical
literature on ependymoma, published between
1969 and 1989, was made to assess the effect
of tumour grade and site, tumour control at the
primary site, and extent of irradiation on the
incidence of spinal seeding after initial
treatment. The pooled data show that the
incidence of seeding was 8.4% (7/83) for high
grade tumours, and 4.5% (6/132) for low grade
tumours. Seeding occurred more frequently in
infratentorial tumours than in supratentorial
tumours. For high grade tumours, the
incidence was 0% (0/26) for supratentorial and
15.7%(6/38) for infratentorial lesions; while for
low grade tumours the respective incidences
were 2.7% (1/37) and 5.5%(4/73). Spinal
seeding was 9.5%(15/157) in the event of
failure at the primary site compared to
3.3%(4/122) when local control was achieved.
The development of spinal metastases was not
influenced by the extent of irradiation. For high
grade tumours the incidence was 9.4%(5/53)
with spinal irradiation, and 6.7%(2/30) without
prophylactic treatment; for low grade tumours
the respective values were 9.3%(4/43) and
2.2%(2189) [16]. Because of rarity of
ependymomas, there has been no prospective,
randomised trial to test the benefits of
extended versus local fields irradiation.
In our study, the dominant pattern of
recurrence was the primary site (11/12=92%).
This was also the case for patients reported by
the Mayo Clinic, Princess Margareth Hospital,
University of California, San Francisco and
University of Florida College of Medicine [9,
17, 18, 19]. In our study of the recurrences,
83% of all cases occurred within the first three
years after treatment initiation, as in that of
other authors [4,18,19].
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In our series, histological grade did not
influence survival, none of the differences
shown in Fig. 2. having reached statistical
significance (p>0.05). These differences can
be regarded as interesting trends, which may
be verified on larger patient populations. The
lack of histopathologic correlation to clinical
outcome was also described by Ross and
Rubinstein [20].
In conclusion, we have found that nearly all
patients who die of ependymoma do so
because of intracranial treatment failure at the
site of the primary tumour. Our current
recommendation is to treat all supratentorial
and low-grade infratentorial tumours, as well
as high-grade supratentorial lesions with partial
brain fields. Even though data in the literature
remains somewhat controversial, we continue
to advocate craniospinal irradiation in patients
with infratentorial anaplastic (grade 3,4)
ependymoma.
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